ASTCT

Influence. Innovate. Growth. ASTCT President Margaret MacMillan, MD, MSc, FRCPC and Past President David Porter, MD, discuss the future of ASTCT and the priorities shaping our 2026–2028 Strategic Plan. Watch to learn more: youtube.com/watch?v=yFvlNP…

The April issue of 'Transplantation and Cellular Therapy,' is now available online: ow.ly/fyyh50YITAj @ELShematology

ASTCT Members - Connect with your SIG through ASTCT's community forums! Within the forums, you can easily share meeting reminders, provide updates and discuss projects. Log in to your ASTCT account today to join your SIG's community forum: ow.ly/Zsj950VssFg

Adenovirus remains an important infectious complication following alloHCT, particularly in the setting of evolving GVHD prophylaxis strategies. This journal club will review a contemporary study evaluating the incidence, timing, and clinical outcomes of adenovirus infection in patients receiving PTCy-based prophylaxis. Register now: ow.ly/xbz750YCYkM

Whether you're looking for your next opportunity in HCT or transplantation, or you're searching for new talent, ASTCT’s Job Connection has you covered! For a limited time, save 15% on job postings with the code ASTCT15. View ASTCT's Career Center: ow.ly/5Ony50YynNG

CAR T cells targeting B7-H3 show promise in treating diffuse intrinsic pontine glioma (DIPG), but researchers suspect the true potential of this approach will only be unlocked by pairing this approach with another intervention. Read more on Nucleus: ow.ly/agHU50YCYwp

Join the ASTCT Pharmacy SIG for the Rx-cited: Clinical Conundrums - Highlights in Hematology session on Apr. 30. This session will review emerging data presented at 2025 ASH, evaluate critical updates in hematology research as it relates to HCT and hematologic malignancies & discuss the impact of therapeutic advancements. Register now: ow.ly/m3Fw50YEGxN

📣 Call for speakers! ASTCT is seeking speakers for the 2026 virtual Clinical Education Conference, taking place Oct. 22-23. The Planning Committee welcomes presenters from a breadth of speaker experiences and backgrounds. Learn more and apply: ow.ly/N8Yj50YCYCH

In this Q&A on Nucleus, new board director Dr. Jennifer Holter-Chakrabarty shares insight into her two-decade plus career in research, what she looks forward to in her new Board role and the role ASTCT has played in her professional development. Read her Q&A: ow.ly/hNzO50YCYuQ

ASTCT is excited to be collaborating with @PharmacyTimesCE for this upcoming live free CE webinar on GvHD! This program will review novel graft-engineering strategies with faculty offering expert analysis on how these precision platforms differ from unmanipulated peripheral blood stem cell or bone marrow grafts. Register now: bit.ly/4c2BRmi

Drawing on her team’s pioneering work—including Europe’s first in vivo genome‑wide CRISPR screens in primary T cells—Dr. Menger will highlight how systematic gene reprogramming can enhance T‑cell persistence, composition, and antitumor function in immunosuppressive environments. Interested in attending this session at the Scientific Meeting? Space is limited, register today: ow.ly/P9vf50YuM62 @TheEBMT

📣 Call for speakers! ASTCT is seeking speakers for the 2026 virtual Clinical Education Conference, taking place Oct. 22-23. The Planning Committee welcomes presenters from a breadth of speaker experiences and backgrounds. Learn more and apply: ow.ly/TcRL50YCYCF

Adenovirus remains an important infectious complication following alloHCT, particularly in the setting of evolving GVHD prophylaxis strategies. This journal club will review a contemporary study evaluating the incidence, timing, and clinical outcomes of adenovirus infection in patients receiving PTCy-based prophylaxis. Register now: ow.ly/xbz750YCYkM

In this episode of ASTCT Talks, host Corey Cutler, MD of Dana-Farber Cancer Institute and Harvard University sits down with Nosha Farhadfar, MD, medical director of research for Sarah Cannon Research Institute’s transplant and cellular therapy program at Methodist Healthcare, and Pooja Khandelwal, MD, an associate professor within the division of bone marrow transplantation at Cincinnati Children’s Hospital Medical Center, to discuss adult and pediatric cGVHD treatment perspectives, including approaches, expert practice experiences and new therapeutics. Listen now: ow.ly/S8TJ50YCQnR

Today, Oncology Pharmacist Day, ASTCT recognizes and sends appreciation to our dedicated pharmacists in oncology who work tirelessly to advance patient care and improve outcomes.

New updates have been made to the ASTCT CAR-T Coding and Billing Guide. Download the guide today to access the latest version: ow.ly/ZwmT50Yyo7S

Adenovirus remains an important infectious complication following allo-HCT, particularly in the setting of evolving GVHD prophylaxis strategies. This journal club will review a contemporary study evaluating the incidence, timing and clinical outcomes of adenovirus infection in patients receiving PTCy-based prophylaxis. Register now: ow.ly/X3W650YBx3p

This review highlights that #CART therapy is feasible for most patients with relapsed or refractory disease, emphasizing the importance of early referral and consultation to improve access and outcomes. Reard the full article: ow.ly/1laV50YCwV1

📣 Final chance to save $50 on Early Bird registration 🎫 #SciMeeting26 From 28-29 May, @ASTCT and @TheEBMT will bring together a select community of leading scientists and clinicians in Philadelphia, USA 🇺🇸 for the 5th edition of the Basic and Translational Scientific Meeting. This highly collaborative conference is dedicated to accelerating progress and discovery in hematopoietic cell transplantation and related cellular therapies. If you are looking for high-value scientific exchange, direct access to peers and a setting built for discovery, this is the meeting to attend. Register with the Early Bird discount by tomorrow, 2 April 2026 at 17:00 CST ⬇️ ebmt.org/events/5th-joi…

In this session, Lai Guan Ng, PhD, will outline how in-depth analysis of pathological granulopoiesis by multiomics and multiparametric technologies can contribute to a better understanding of neutrophil subsets and the discovery of new functions. Interested in attending this session? Register by tomorrow to receive the lowest rate to the Scientific Meeting: ow.ly/P9vf50YuM62 @TheEBMT